Dr. Curtis Baum, MD
Claim this profileCotton O'Neil Clinical Research Center
Studies Ulcerative Colitis
Studies Inflammatory Bowel Disease
5 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Curtis Baum, MD is currently running
ABX464
for Ulcerative Colitis
This is a multicenter, randomized, placebo controlled study to evaluate the efficacy and safety of ABX464 given at 25 or 50 mg QD in inducing clinical remission in subjects with moderately to severely active ulcerative colitis who have inadequate response, no response, a loss of response, or an intolerance to either conventional therapies [corticosteroids, immunosuppressant (i.e. azathioprine, 6-mercaptopurine, methotrexate)] and/or advanced therapies [biologics (TNF inhibitors, anti-integrins, anti-IL-23), and/or S1P receptor modulators, and/or JAK inhibitors].
Recruiting1 award Phase 36 criteria
Mirikizumab
for Ulcerative Colitis
This trial is testing mirikizumab, a medication for people with severe ulcerative colitis. It aims to see if the drug can reduce gut inflammation by blocking a protein that causes it. The study will last several years. Mirikizumab has shown positive results in early tests for ulcerative colitis.
Recruiting2 awards Phase 31 criteria
More about Curtis Baum, MD
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Curtis Baum, MD has experience with
- ABX464
- Mirikizumab
- Vedolizumab
- Adalimumab
- Ustekinumab
Breakdown of trials Curtis Baum, MD has run
Ulcerative Colitis
Inflammatory Bowel Disease
Ulcer
Crohn's Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Curtis Baum, MD specialize in?
Curtis Baum, MD focuses on Ulcerative Colitis and Inflammatory Bowel Disease. In particular, much of their work with Ulcerative Colitis has involved treating patients, or patients who are undergoing treatment.
Is Curtis Baum, MD currently recruiting for clinical trials?
Yes, Curtis Baum, MD is currently recruiting for 4 clinical trials in Topeka Kansas. If you're interested in participating, you should apply.
Are there any treatments that Curtis Baum, MD has studied deeply?
Yes, Curtis Baum, MD has studied treatments such as ABX464, Mirikizumab, Vedolizumab.
What is the best way to schedule an appointment with Curtis Baum, MD?
Apply for one of the trials that Curtis Baum, MD is conducting.
What is the office address of Curtis Baum, MD?
The office of Curtis Baum, MD is located at: Cotton O'Neil Clinical Research Center, Topeka, Kansas 66606 United States. This is the address for their practice at the Cotton O'Neil Clinical Research Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.